XML 13 R4.htm IDEA: XBRL DOCUMENT v3.10.0.1
Interim Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Operating expenses:        
Research and development $ (2,217) $ (1,144) $ (6,478) $ (2,419)
Marketing and sales (234) (263) (775) (776)
General and administrative (872) (684) (2,813) (3,021)
Operating loss (3,323) (2,091) (10,066) (6,216)
Equity in net loss of an affiliated company (1,035) (343) (2,112) (726)
Financing income (expenses), net 600 6,900 6,935 (15,494)
Net (loss) profit $ (3,758) $ 4,466 $ (5,243) $ (22,436)
Basic and diluted net (loss) profit per share from continuing operations $ (0.03) $ 0.04 $ (0.04) $ (0.25)
Weighted average number of shares outstanding used in computing basic and diluted net (loss) profit per share 130,074,456 104,651,543 116,796,168 89,699,607